AI assistant
Hill & Smith PLC — Director's Dealing 2026
Apr 2, 2026
4647_dirs_2026-04-02_f4200e2e-d191-4196-b694-9d584578d411.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 2978Z
Hill & Smith PLC
02 April 2026
2 April 2026
Hill & Smith PLC
Director/PDMR Shareholding
Hill & Smith PLC (the 'Company' or 'Hill & Smith') announces that it has been notified that on 1 April 2026 Mr Alan Giddins, Chair, transferred 29,000 ordinary shares in the Company ('Ordinary Shares') as a charitable donation by way of a gift for nil consideration to the National Philanthropic Trust UK Limited (Charity Registration Number - 1181128).
As a result of this transaction, Mr Giddins now has a beneficial interest in 68,350 Ordinary Shares.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| (a) | Name | Alan Giddins | |
| 2. | Reason for the notification | ||
| (a) | Position/status | Chair | |
| (b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer | ||
| (a) | Name | Hill & Smith PLC | |
| (b) | LEI | 2138003A3ISGQZBOWI83 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the Financial Instrument | Ordinary Shares of £0.25 each | |
| (b) | Identification code of the Financial Instrument | GB0004270301 | |
| (c) | Nature of the transactions | Transfer of shares to charity for nil consideration. | |
| (d) | Price and volume | Price(s) | Volume(s) |
| Nil | 29,000 | ||
| (e) | Aggregated information | N/A | |
| - Aggregated volume | N/A | ||
| - Price | N/A | ||
| (f) | Date of the transaction | 1 April 2026 | |
| (g) | Place of the transaction | Outside a trading venue |
Enquiries:
Karen Atterbury
Group Company Secretary
0121 704 7430
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHAKBBDDBKDPQK